Total Payments
$10,255
2024 Payments
$1,278
Companies
53
Transactions
834
Medicare Patients
3,665
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$10,144 (98.9%)
Education$110.38 (1.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,144 | 826 | 98.9% |
| Education | $110.38 | 8 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Collegium Pharmaceutical, Inc. | $2,074 | 188 | $0 (2024) |
| Abbott Laboratories | $1,705 | 169 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,361 | 122 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $760.52 | 59 | $0 (2024) |
| PFIZER INC. | $471.34 | 48 | $0 (2021) |
| Egalet US Inc | $389.14 | 36 | $0 (2018) |
| Purdue Pharma L.P. | $386.45 | 26 | $0 (2018) |
| SCILEX PHARMACEUTICALS INC. | $271.92 | 19 | $0 (2024) |
| Bioventus LLC | $247.18 | 14 | $0 (2019) |
| BioDelivery Sciences International, Inc. | $237.54 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,278 | 78 | Collegium Pharmaceutical, Inc. ($266.50) |
| 2023 | $883.68 | 66 | Collegium Pharmaceutical, Inc. ($297.25) |
| 2022 | $912.79 | 73 | Collegium Pharmaceutical, Inc. ($333.50) |
| 2021 | $823.18 | 81 | Collegium Pharmaceutical, Inc. ($286.33) |
| 2020 | $853.31 | 80 | Abbott Laboratories ($295.14) |
| 2019 | $1,234 | 118 | Abbott Laboratories ($440.21) |
| 2018 | $1,929 | 163 | Daiichi Sankyo Inc. ($467.22) |
| 2017 | $2,341 | 175 | Daiichi Sankyo Inc. ($616.60) |
All Payment Transactions
834 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.93 | General |
| Category: Opioid Analgesic | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $5.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Analgesic | ||||||
| 10/31/2024 | DePuy Synthes Sales Inc. | ORTHOVISC (Device), MONOVISC | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: Sports Early Intervention | ||||||
| 10/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.69 | General |
| Category: Opioid Analgesic | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Gastroenterology | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Gastroenterology | ||||||
| 10/07/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Opioid Analgesic | ||||||
| 10/03/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/01/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Neurology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Analgesic | ||||||
| 09/17/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Gastroenterology | ||||||
| 09/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.11 | General |
| Category: Opioid Analgesic | ||||||
| 08/28/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Neuromodulation | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $9.44 | General |
| Category: Opioid Analgesic | ||||||
| 08/23/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Pain Management | ||||||
| 08/20/2024 | Valinor Pharma, LLC | MOVANTIK (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 839 | 2,869 | $686,570 | $221,260 |
| 2022 | 14 | 930 | 3,955 | $789,690 | $251,037 |
| 2021 | 15 | 917 | 6,283 | $860,945 | $283,187 |
| 2020 | 18 | 979 | 19,574 | $914,786 | $248,834 |
Total Patients
3,665
Total Services
32,681
Medicare Billing
$1.0M
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 225 | 1,589 | $281,280 | $111,266 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 499 | $134,815 | $50,812 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $31,050 | $8,945 | 28.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 61 | 153 | $13,005 | $8,582 | 66.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 24 | 80 | $14,580 | $8,056 | 55.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 61 | 61 | $10,675 | $6,694 | 62.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 14 | 22 | $24,480 | $6,023 | 24.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 25 | 33 | $35,910 | $5,975 | 16.6% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 21 | 51 | $38,250 | $4,022 | 10.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 21 | 73 | $47,340 | $3,907 | 8.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 42 | 73 | $36,500 | $3,554 | 9.7% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 27 | 56 | $15,400 | $2,766 | 18.0% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 12 | 19 | $2,375 | $649.71 | 27.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 50 | 91 | $910.00 | $8.90 | 1.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 240 | 1,723 | $305,850 | $124,284 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 139 | 328 | $88,465 | $34,645 | 39.2% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 92 | 285 | $24,315 | $15,478 | 63.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 104 | 104 | $43,300 | $13,977 | 32.3% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2022 | 13 | 864 | $54,000 | $11,804 | 21.9% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2022 | 35 | 111 | $19,980 | $11,709 | 58.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2022 | 30 | 42 | $47,250 | $8,254 | 17.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 73 | 75 | $13,125 | $7,836 | 59.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 30 | 102 | $68,460 | $5,736 | 8.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2022 | 33 | 58 | $42,750 | $4,977 | 11.6% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2022 | 12 | 17 | $18,000 | $4,739 | 26.3% |
About Dr. Ted Freeman, DO
Dr. Ted Freeman, DO is a Pain Medicine healthcare provider based in Brick, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881762029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ted Freeman, DO has received a total of $10,255 in payments from pharmaceutical and medical device companies, with $1,278 received in 2024. These payments were reported across 834 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,144).
As a Medicare-enrolled provider, Freeman has provided services to 3,665 Medicare beneficiaries, totaling 32,681 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Brick, NJ
- Active Since 12/04/2006
- Last Updated 10/27/2008
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1881762029
Products in Payments
- XTAMPZA (Drug) $1,649
- Morphabond ER (Drug) $837.76
- RELISTOR (Drug) $760.52
- Octrode SCS Leads (Device) $661.82
- Movantik (Drug) $536.76
- LYRICA (Drug) $340.18
- Xtampza ER (Drug) $282.15
- OCTRODE (Device) $277.95
- MOVANTIK (Drug) $260.55
- Proclaim Family of SCS IPGs (Device) $243.82
- GELSYN 3 (Device) $223.89
- ARYMO ER (Drug) $223.51
- SPRINT PNS System (Device) $190.05
- ZTLido (Drug) $188.24
- RELISTOR ORAL (Drug) $183.97
- HYMOVIS (Device) $136.84
- ORTHOVISC (Device) $127.18
- Swift-Lock SCS (Device) $126.82
- BUNAVAIL 2.1 mg 30-count box (Drug) $119.25
- OXAYDO (Drug) $118.34
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.